Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases,
called the new work a «significant advance,» noting in a statement that it «opens the way to producing [monoclonal antibodies] that potentially could be used diagnostically or therapeutically» for the flu as well as other infectious diseases such as hepatitis C and the
human immunodeficiency virus (HIV), which can lead to full - blown AIDS.